The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada.

作者: Eric I Benchimol , Charles N Bernstein , Alain Bitton , Sanjay K Murthy , Geoffrey C Nguyen

DOI: 10.1093/JCAG/GWY052

关键词:

摘要: Canada has among the highest rates of IBD in world, and number people living with these disorders is growing rapidly. This placed a high burden on health care system Canadian economy-a that only expected to grow future. It important understand its impact society order appropriately plan for expenditures, reduce patients their families, improve quality life those afflicted IBD. In Canada, there lack public awareness Crohn's disease ulcerative colitis. Raising crucial reducing social stigma common diseases help individuals maximize overall life. A better understanding can also raise direct funds research, which could lead improved treatments and, ultimately, cure. report from clinicians researchers Colitis makes recommendations aimed at public, policy-makers, scientific funding agencies, charitable foundations regarding future directions advocacy efforts areas emphasize research spending. The identifies gaps knowledge fields clinical, systems epidemiological research.

参考文章(60)
Helen M Becker, Daniel Grigat, Subrata Ghosh, Gilaad G Kaplan, Levinus Dieleman, Eytan Wine, Richard N Fedorak, Aida Fernandes, Remo Panaccione, Herman W Barkema, Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey. Canadian Journal of Gastroenterology & Hepatology. ,vol. 29, pp. 77- 84 ,(2015) , 10.1155/2015/815820
Peter Stepaniuk, Charles N Bernstein, Laura E Targownik, Harminder Singh, Characterization of Inflammatory Bowel Disease in Elderly Patients: A Review of Epidemiology, Current Practices and Outcomes of Current Management Strategies Canadian Journal of Gastroenterology & Hepatology. ,vol. 29, pp. 327- 333 ,(2015) , 10.1155/2015/136960
Tamara Pringsheim, Nathalie Jette, Alexandra Frolkis, Thomas D.L. Steeves, The prevalence of Parkinson's disease: A systematic review and meta‐analysis Movement Disorders. ,vol. 29, pp. 1583- 1590 ,(2014) , 10.1002/MDS.25945
Marie-Paule Roth, Gloria M. Petersen, Colleen McElree, Constance M. Vadheim, Joel F. Panish, Jerome I. Rotter, Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews Gastroenterology. ,vol. 96, pp. 1016- 1020 ,(1989) , 10.1016/0016-5085(89)91618-1
Johanna Haapamäki, Risto P Roine, Harri Sintonen, Kaija-Leena Kolho, Health‐related quality of life in paediatric patients with inflammatory bowel disease related to disease activity Journal of Paediatrics and Child Health. ,vol. 47, pp. 832- 837 ,(2011) , 10.1111/J.1440-1754.2011.02034.X
Ashwin N. Ananthakrishnan, Emily L. McGinley, David G. Binion, Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflammatory Bowel Diseases. ,vol. 15, pp. 182- 189 ,(2008) , 10.1002/IBD.20628
Charles N. Bernstein, Extraintestinal manifestations of inflammatory bowel disease. Current Gastroenterology Reports. ,vol. 3, pp. 477- 483 ,(2001) , 10.1007/S11894-001-0068-6
Michele Herzer, Lee A Denson, Robert N Baldassano, Kevin A Hommel, Patient and Parent Psychosocial Factors Associated with Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease Journal of Pediatric Gastroenterology and Nutrition. ,vol. 52, pp. 295- 299 ,(2011) , 10.1097/MPG.0B013E3181F5714E
Eric I Benchimol, David R Mack, Astrid Guttmann, Geoffrey C Nguyen, Teresa To, Nassim Mojaverian, Pauline Quach, Douglas G Manuel, Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. The American Journal of Gastroenterology. ,vol. 110, pp. 553- 563 ,(2015) , 10.1038/AJG.2015.52
Mario Cottone, Anna Kohn, Marco Daperno, Alessandro Armuzzi, Luisa Guidi, Renata D'Inca, Fabrizio Bossa, Erika Angelucci, Livia Biancone, Paolo Gionchetti, Sandro Ardizzone, Claudio Papi, Walter Fries, Silvio Danese, Gabriele Riegler, Maria Cappello, Fabiana Castiglione, Vito Annese, Ambrogio Orlando, None, Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clinical Gastroenterology and Hepatology. ,vol. 9, pp. 30- 35 ,(2011) , 10.1016/J.CGH.2010.09.026